Mariko Nakahara, Naoya Murakami, Takahito Chiba, Ayaka Nagao, Kae Okuma, Tairo Kashihara, Tomoya Kaneda, Kana Takahashi, Koji Inaba, Yuko Nakayama, Tomoyasu Kato, Hiroshi Igaki
BACKGROUND: Despite its efficacy, if adherence to dose constraints for surrounding normal tissues proves unattainable, the risk of late radiation-related adverse events after primary radiotherapy involving brachytherapy remains a noteworthy concern. Some studies suggest that similar to prostate radiotherapy, spacers may potentially reduce doses to surrounding healthy rectal or bladder tissues. However, guidance on spacer injections for gynecologic brachytherapy is scarce, and the optimal anatomical location for spacer placement remains undefined...
2024: Brachytherapy